Pre COVID-19 period | COVID-19 period | |||||||
---|---|---|---|---|---|---|---|---|
Variables | HADS < 8 group (n = 1334) | HADS ≥ 8 group (n = 1379) | P | Effect size | HADS < 8 group (n = 489) | HADS ≥ 8 group (n = 459) | P | Effect size |
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||||
Age | 63.12 (11.00) | 60.47 (10.80) | < 0.001 | 0.24 | 63.63 (10.56) | 59.70 (11.12) | < 0.001 | 0.36 |
Total comorbidities | 4.55 (2.13) | 5.12 (2.26) | < 0.001 | 0.26 | 4.54 (2.16) | 5.04 (2.25) | = 0.001 | 0.23 |
Weight (kg) | 85.25 (18.71) | 87.94 (21.30) | = 0.001 | 0.13 | 83.95 (19.36) | 87.38 (20.45) | = 0.011 | 0.17 |
HADS anxiety score measurement | 6.48 (3.81) | 11.92 (4.06) | < 0.001 | 1.38 | 6.18 (3.64) | 11.58 (4.25) | < 0.001 | 1.37 |
 | % | % |  |  | % | % |  |  |
Female % | 36.1 | 36.4 | 0.849 | 0.00 | 34.2 | 39.6 | 0.087 | 0.05 |
Comorbid anxiety (yes) % | 48.9 | 60.2 | < 0.001 | 0.11 | 47.9 | 57.3 | 0.004 | 0.10 |
150 min. physical activity a week (yes) % | 52.5 | 29.2 | < 0.001 | 0.24 | 48.7 | 30.0 | < 0.001 | 0.19 |
Smoking (Yyes) % | 8.4 | 19.9 | < 0.001 | 0.16 | 11.3 | 17.7 | 0.006 | 0.09 |
Partnered % | 69.0 | 62.3 | 0.001 | 0.07 | 67.6 | 58.3 | 0.008 | 0.10 |
IMD (most deprived) % | 15.9 | 28.1 | < 0.001 | 0.15 | 16.2 | 29.8 | < 0.001 | 0.16 |